Clinical Trial Update: Serum and Tissue Cefazolin Concentrations in Patients Undergoing Cesarean Delivery [Phase 4]

View source ↗

Summary

Phase 4 study evaluating serum and tissue concentrations of cefazolin in patients undergoing cesarean delivery and its relation to surgical site infection risk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Surgical Site Infection

Drugs mentioned

• CEFAZOLIN (cefazolin sodium)

Snippet

Sponsor: Michael Stitely | Conditions: Cesarean Delivery, Wound Infection | Phase 4 | Status: COMPLETED | Results posted: 2013-08-21